Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Hypnotics' association with mortality or cancer: a matched cohort study.

Kripke DF, Langer RD, Kline LE.

BMJ Open. 2012 Feb 27;2(1):e000850. doi: 10.1136/bmjopen-2012-000850. Print 2012.

2.

Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study.

Weich S, Pearce HL, Croft P, Singh S, Crome I, Bashford J, Frisher M.

BMJ. 2014 Mar 19;348:g1996. doi: 10.1136/bmj.g1996.

3.

Melatonin, hypnotics and their association with fracture: a matched cohort study.

Frisher M, Gibbons N, Bashford J, Chapman S, Weich S.

Age Ageing. 2016 Nov;45(6):801-806. Epub 2016 Jul 26.

PMID:
27496941
4.

Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.

Mason M, Cates CJ, Smith I.

Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Review.

PMID:
26171909
5.

Sedative Hypnotic Medication Use and the Risk of Motor Vehicle Crash.

Hansen RN, Boudreau DM, Ebel BE, Grossman DC, Sullivan SD.

Am J Public Health. 2015 Aug;105(8):e64-9. doi: 10.2105/AJPH.2015.302723. Epub 2015 Jun 11.

PMID:
26066943
6.

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Kripke DF.

F1000Res. 2016 May 19;5:918. doi: 10.12688/f1000research.8729.1. eCollection 2016. Review.

7.

Association of hypnotics with stroke risk: a population-based case-control study.

Lee CC, Tsai KY, Hung YT, Chou FH, Huang YS.

Prim Care Companion CNS Disord. 2014;16(2). pii: PCC.13m01583. doi: 10.4088/PCC.13m01583. Epub 2014 Mar 27.

8.

Long-term use of zolpidem increases the risk of major injury: a population-based cohort study.

Lai MM, Lin CC, Lin CC, Liu CS, Li TC, Kao CH.

Mayo Clin Proc. 2014 May;89(5):589-94. doi: 10.1016/j.mayocp.2014.01.021. Epub 2014 Mar 29.

PMID:
24684782
9.

New and chronic use of hypnotics after diagnosis with early breast cancer. A retrospective cohort study.

Andersen LT, Suppli NP, Dalton SO, Kroman N, Rosenberg J, Gögenur I.

Acta Oncol. 2015 May;54(5):704-11. doi: 10.3109/0284186X.2014.998276. Epub 2015 Mar 9.

PMID:
25752966
10.

Benzodiazepine and sedative-hypnotic use among older seriously Ill veterans: choosing wisely?

Garrido MM, Prigerson HG, Penrod JD, Jones SC, Boockvar KS.

Clin Ther. 2014 Nov 1;36(11):1547-54. doi: 10.1016/j.clinthera.2014.10.007. Epub 2014 Nov 4.

PMID:
25453732
11.

Mortality hazard associated with prescription hypnotics.

Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L.

Biol Psychiatry. 1998 May 1;43(9):687-93.

PMID:
9583003
12.

Psychological treatment for insomnia in the regulation of long-term hypnotic drug use.

Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M.

Health Technol Assess. 2004 Feb;8(8):iii-iv, 1-68. Review.

13.

Survey of hypnotic drug use in nursing homes.

James DS.

J Am Geriatr Soc. 1985 Jun;33(6):436-9.

PMID:
3998353
14.

Sedative-hypnotics are widely abused by drivers apprehended for driving under the influence of drugs.

Kriikku P, Hurme H, Wilhelm L, Rintatalo J, Hurme J, Kramer J, Ojanperä I.

Ther Drug Monit. 2015 Jun;37(3):339-46. doi: 10.1097/FTD.0000000000000138.

PMID:
25254415
15.

Pharmacokinetics and drug interactions of the sedative hypnotics.

Wang JS, DeVane CL.

Psychopharmacol Bull. 2003 Winter;37(1):10-29. Review.

PMID:
14561946
16.

Gender and use of hypnotics or sedatives in old age: a nationwide register-based study.

Johnell K, Fastbom J.

Int J Clin Pharm. 2011 Oct;33(5):788-93. doi: 10.1007/s11096-011-9536-8. Epub 2011 Jul 6.

PMID:
21732166
17.

'Hypnotic' prescription patterns in a large managed-care population.

Roehrs T, Roth T.

Sleep Med. 2004 Sep;5(5):463-6.

PMID:
15341891
18.

Main neuroendocrine features and therapy in primary sleep troubles.

Amihăesei IC, Mungiu OC.

Rev Med Chir Soc Med Nat Iasi. 2012 Jul-Sep;116(3):862-6.

PMID:
23272543
19.

Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Dassanayake T, Michie P, Carter G, Jones A.

Drug Saf. 2011 Feb 1;34(2):125-56. doi: 10.2165/11539050-000000000-00000. Review.

PMID:
21247221
20.

Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.

Linnet K, Gudmundsson LS, Birgisdottir FG, Sigurdsson EL, Johannsson M, Tomasdottir MO, Sigurdsson JA.

BMC Fam Pract. 2016 Jun 6;17:69. doi: 10.1186/s12875-016-0469-0.

Supplemental Content

Support Center